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Abstract
Diets enriched in fructose (FR) increase lipogenesis in the liver, leading to hepatic lipid accumulation and the
development of insulin resistance. Previously, we have shown that in contrast to other mouse strains, BALB/c
mice are resistant to high fat diet-induced metabolic deterioration, potentially due to a lack of ectopic lipid
accumulation in the liver. In this study we have compared the metabolic response of BALB/c and C57BL/6
(BL6) mice to a fructose-enriched diet. Both strains of mice increased adiposity in response to FR-feeding,
while only BL6 mice displayed elevated hepatic triglyceride (TAG) accumulation and glucose intolerance. The
lack of hepatic TAG accumulation in BALB/c mice appeared to be linked to an altered balance between
lipogenic and lipolytic pathways, while the protection from fructose-induced glucose intolerance in this strain
was likely related to low levels of ER stress, a slight elevation in insulin levels and an altered profile of
diacylglycerol species in the liver. Collectively these findings highlight the multifactorial nature of metabolic
defects that develop in response to changes in the intake of specific nutrients and the divergent response of
different mouse strains to dietary challenges.
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Disparate metabolic response  
to fructose feeding between 
different mouse strains
M. K. Montgomery1, C. E. Fiveash1, J. P. Braude1, B. Osborne1, S. H. J. Brown2,3, 
T. W. Mitchell2,3 & N. Turner1
Diets enriched in fructose (FR) increase lipogenesis in the liver, leading to hepatic lipid accumulation 
and the development of insulin resistance. Previously, we have shown that in contrast to other mouse 
strains, BALB/c mice are resistant to high fat diet-induced metabolic deterioration, potentially due to a 
lack of ectopic lipid accumulation in the liver. In this study we have compared the metabolic response of 
BALB/c and C57BL/6 (BL6) mice to a fructose-enriched diet. Both strains of mice increased adiposity in 
response to FR-feeding, while only BL6 mice displayed elevated hepatic triglyceride (TAG) accumulation 
and glucose intolerance. The lack of hepatic TAG accumulation in BALB/c mice appeared to be linked 
to an altered balance between lipogenic and lipolytic pathways, while the protection from fructose-
induced glucose intolerance in this strain was likely related to low levels of ER stress, a slight elevation 
in insulin levels and an altered profile of diacylglycerol species in the liver. Collectively these findings 
highlight the multifactorial nature of metabolic defects that develop in response to changes in the 
intake of specific nutrients and the divergent response of different mouse strains to dietary challenges.
Obesity, insulin resistance and related metabolic health issues have escalated globally to epidemic levels. One of the 
major factors proposed to underpin this dramatic increase in the incidence of metabolic disease is excess caloric 
intake. While much of the focus in this area has been on increases in lipid intake, there is accumulating evidence 
that diets enriched in fructose (FR) also contribute to the risks of the metabolic syndrome1. Upon dietary intake, 
fructose is directly transported to the liver via the portal vein, where it is able to bypass several of the control steps 
of glucose metabolism (including phosphofructokinase), and therefore serves as an unregulated source of both 
glycerol 3-phosphate and acetyl-CoA2. The liver responds to flooding with acetyl-CoA by increasing lipogenic 
pathways and storing excess energy in form of triglycerides3. Ectopic lipid accumulation is further accelerated by 
elevated malonyl-CoA levels (the product of acetyl-CoA carboxylase), which inhibits CPT1, leading to reduced 
entry of fatty acids into mitochondria for oxidation4. Accordingly, excess hepatic lipid storage is a key characteristic 
observed in both rodents and humans after acute and long-term fructose intake2,5–7.
Elevated fructose consumption is also known to adversely impact whole body glucose tolerance and insulin 
sensitivity (summarised in8), however the mechanisms responsible for these effects are still not completely under-
stood. While there are some discrepancies between different studies, livers from FR–fed rodents frequently exhibit 
(1) diacylglycerol (DAG) accumulation9–11, (2) activation of inflammatory and stress signalling pathways, including 
activation of c-Jun N-terminal kinases (JNK) and endoplasmic reticulum stress markers12–17 and (3) inhibition of 
components of the insulin signalling cascade10,15,17–19.
Mouse strains differ in their metabolic response to high calorie diets20–24, and we have recently shown that 
BALB/c mice are protected against high-fat diet-induced glucose intolerance and insulin resistance24. This favour-
able metabolic phenotype of BALB/c mice was strongly related to a lack of hepatic lipid accumulation24. Given that 
excess lipid deposition in the liver is a major factor driving metabolic dysfunction in response to FR-enriched diets, 
our goals in this study were to examine if BALB/c mice were also refractory to the metabolic defects induced by 
FR feeding and to additionally investigate the potential mechanisms connecting hepatic lipid accumulation with 
impaired glucose metabolism in this model.
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Results
Body weight, adiposity and food intake. Body weight was unchanged in FR-fed BL6 and BALB/c mice 
when compared to chow diet (C)-fed control mice (Fig. 1A). Adiposity, indicated as percent fat mass (measured by 
EchoMRI) (Fig. 1B) and by the size of the epididymal, inguinal and retroperitoneal fat pads (Table 1), was increased 
in both mouse strains after FR-feeding. In contrast, liver and brown adipose tissue (BAT) weight was unchanged in 
FR-fed mice (Table 1). Food intake was measured weekly as an average of six cages with four mice per cage for each 
strain. Energy intake (in kcal/day/mouse) tended to be increased in both mouse strains on the FR-diet (+ 8.9% in 
BL6 mice and + 8.6% in BALB/c mice), although this did not reach statistical significance.
Circulating factors. In BL6 mice, plasma TAG were significantly decreased after FR-feeding and a similar 
trend was observed for non-esterified fatty acids (NEFA). In BALB/c mice, plasma TAG showed a similar reduc-
tion with FR-feeding, while plasma NEFA were significantly increased when compared to control BALB/c mice 
(Table 1). Fasting blood glucose and insulin levels remained unchanged with FR-feeding in both mouse strains 
(Table 1).
Energy Expenditure and Fuel Selection. Energy expenditure was increased in FR-fed BL6 mice (+ 27%), 
but not in BALB/c mice, and ANCOVA analysis using (lean body mass + 0.2x fat mass) as a covariate25 indicated 
this difference in BL6 mice was significant (Fig. 1C). The respiratory exchange ratio (RER) was decreased in BL6 
mice but remained unchanged in FR-fed BALB/c mice (Fig. 1D).
Glucose tolerance and Insulin levels. An intraperitoneal glucose tolerance test (GTT) was carried out 
as a measure of whole-body glucose clearance. FR-fed BL6 mice exhibited a substantial impairment in glucose 
clearance as evidenced by a significant increase in the incremental glucose AUC (+ 63%, Fig. 1E), while in contrast 
glucose tolerance was unaffected by FR-feeding in BALB/c mice (Fig. 1F). Blood insulin levels during the GTT were 
unchanged in FR-fed BL6 mice when compared to the control group (Fig. 1G), but were significantly increased at 
later time points in BALB/c mice (Fig. 1H).
Ectopic lipid accumulation in the liver. Liver TAG were significantly increased in BL6 mice after FR-feeding 
(+ 225%), whereas excess TAG accumulation was absent in FR-fed BALB/c mice (Fig. 2A). These differences in 
hepatic lipid accumulation were unlikely due to differences in fructose utilization as fructokinase activity was 
increased to a similar extent in both strains after FR-feeding (BL6 C-diet 2.60 ± 0.34 FR-diet 5.07 ± 0.73*; BALB/c 
C-diet 2.16 ± 0.32 FR-diet 5.93 ± 0.64*** nmol/min/mg protein). Total diacylglycerol (DAG) content was increased 
in both FR-fed mouse strains when compared to controls (Fig. 2B), while in contrast there was a significant decrease 
in total ceramide (CER) content (Fig. 2C).
In addition, we observed striking differences in DAG species composition. Saturated (SFA) DAG species (sat-
urated fatty acid at both the sn1 and sn2 position) remained largely unaffected by diet in both mouse strains 
(Fig. 2D), monounsaturated (MUFA) DAG species significantly increased in both strains (Fig. 2E), but it was 
the highly active polyunsaturated (PUFA) DAG species26 that exhibited strain-specific differences [DAG were 
classified as MUFA- or PUFA-DAG when at least one of two fatty acids was monounsaturated or polyunsaturated, 
respectively]. While total PUFA-DAG tended to increase in FR-fed BL6 mice (p = 0.062), they were significantly 
reduced in FR-fed BALB/c mice when compared to controls (Fig. 2F). Furthermore, 20:4-containing DAG species, 
that have previously been reported to potently activate protein kinase C (PKC)27, were either significantly decreased 
in FR-fed BALB/c mice but increased in BL6 mouse livers (18:0–20:4, Fig. 2H), or increased in both mouse strains, 
however to a much lesser extent in BALB/c mice (16:0–20:4, Fig. 2G, and 18:1–20:4, Fig. 2I).
Lipid metabolism in the liver. To investigate possible mechanisms for the observed differences in 
fructose-mediated ectopic lipid accumulation in the liver between BL6 and BALB/c mice, we took a comprehensive 
look at various hepatic lipid metabolism pathways, including lipogenesis, lipolysis, oxidation and lipid secretory 
pathways (Fig. 3). Consistent with the known effect of fructose to upregulate lipogenic pathways, protein contents 
of both acetyl-CoA carboxylase isoforms (ACC1 and ACC2), fatty acid synthase (FAS) and stearoyl-CoA desaturase 
(SCD1), were substantially elevated in FR-fed BL6 mice. Intriguingly, the protein levels of these lipogenic enzymes 
were also markedly upregulated in FR-fed BALB/c mice (Fig. 3A), despite the fact that TAG levels were unchanged. 
To determine if changes in protein content of lipogenic proteins correlated with changes in actual lipogenic capacity, 
we isolated primary hepatocytes from BL6 and BALB/c mice that were fed a chow- or FR-diet for 2 weeks, with 
subsequent overnight incubation of hepatocytes in FR-enriched media. This length of FR-feeding is sufficient to 
drive changes in lipogenesis in mice13,15. Similar to our observations in mouse liver, primary hepatocytes from 
FR-fed BL6 mice, but not BALB/c mice, showed increased TAG accumulation (Fig. 3B). Interestingly, lipogenesis, 
measured as the incorporation of [3H]H2O into the TAG pool, was significantly increased in FR-fed BL6 mice 
(in accordance with changes in ACC, FAS and SCD1), but remained unaffected by fructose exposure in BALB/c 
mice (Fig. 3C). Despite similar increases in the protein content of lipogenic markers in both mouse strains with 
FR-feeding, the tracer experiments suggested that BALB/c mice have a lower capacity to synthesise hepatic lipid 
from exogenous fructose. In addition to lipogenesis, a further mechanism known to affect hepatic lipid content is 
the breakdown of stored triglycerides, ie. lipolysis. The lipolytic enzymes adipose triglyceride lipase (ATGL) and 
hormone-sensitive lipase (HSL) were both significantly decreased in FR-fed BL6 mice when compared to control 
BL6 mice, but remained unchanged in BALB/c mice after FR-feeding (Fig. 3A), potentially pointing towards 
BALB/c mice being able to quickly degrade newly synthesised TAG. To verifiy the relevance of these immublotting 
results, we used [1-14C]palmitate to determine the esterification rate (= incorporation of exogenous FA into the 
lipid pool) and lipolytic capacity (= priming of the lipid pool with labelled palmitate, and subsequent determina-
tion of TAG breakdown) in primary hepatocytes. Whereas the esterification rate was reduced in FR-fed BALB/c 
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Figure 1. Metabolic characteristics in chow- and fructose-fed BL6 and BALB/c mice. Shown are (A) body 
weight, (B) fat mass, (C) energy expenditure (shown as heat production), (D) respiratory exchange ratio, as 
well as glucose tolerance curves in BL6 (E) and BALB/c (F) mice, and insulin levels during the GTT in BL6 
(G) and BALB/c (H) mice. Black bars/dots = chow-fed mice, grey bars/dots = fructose-fed mice; shown are 
means ± SEM, with n = 26 (A), n = 8–12 (B–H); *p < 0.05, **p < 0.01, ***p < 0.001.
www.nature.com/scientificreports/
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mice (Fig. 3D), lipolytic capacity was significantly increased (Fig. 3E). In contrast, both measures were unaffected 
by FR-feeding in BL6 mice.
An additional process that can affect the total level of lipid storage in the liver is the extent of lipid export. To 
assess this we measured hepatic triglyceride secretion rate in vivo (using Poloxamer 407) in BL6 and BALB/c mice 
fed a FR-enriched diet for 8 weeks. Unexpectedly, FR-fed BL6 mice exhibited a significantly increased rate of TAG 
secretion (+ 67% at the 6-hour timepoint) when compared to control BL6 mice (Fig. 3F), whereas TAG secretion 
was unchanged in FR-fed BALB/c mice (Fig. 3G). These results are supported by a similar observation made in pri-
mary hepatocytes, with hepatocytes from FR-fed BL6 mice but not BALB/c mice showing a significantly increased 
rate of TAG secretion (Fig. 3H). In contrast NEFA secretion into the media from primary hepatocytes tended to 
be higher in BALB/c mice, but was unaffected by diet in both mouse strains (Fig. 3I).
Taken together, the results suggest that the lack of excess TAG storage in BALB/c mice in response to FR-feeding 
is partially explained by an altered balance between lipogenesis and lipolysis, as well as potentially reduced incor-
poration of exogenous FA into their hepatic lipid pool. This is interesting, as both mouse strains exhibit a moderate 
increase in the protein levels of some fatty acid uptake proteins, including fatty acid transport protein 2 (FATP2) 
and FATP4 (Fig. 3A).
Oxidative metabolism in the liver. In addition to the parameters measured above, changes in fatty acid 
oxidative metabolism may also contribute to the strain-specific differences in ectopic lipid accumulation in the 
liver. Whereas protein content of various oxidative markers, including subunits of the complexes of the electron 
transport chain (ETC), peroxisome proliferator-activated receptor gamma coactivator 1α (PGC1α ), the mitochon-
drial transcriptional activator TFAM and carnitine palmitoyltransferase 1 (CPT1), remained largely unaffected 
by diet in both mouse strains (Fig. 4A), citrate synthase activity was significantly increased in both mouse strains 
after FR-feeding (Fig. 4B). Interestingly, β HAD (β -Hydroxy acyl-CoA dehydrogenase) activity (Fig. 4C) as well as 
palmitate oxidation (using [1-14C]palmitate in isolated hepatocytes) (Fig. 4D) were reduced in FR-fed BL6 mice, 
but in contrast were higher in FR-fed BALB/c mice when compared to controls, suggesting increased capacity to 
oxidize lipids in FR-fed BALB/c mice is another factor likely contributing to the absence of excess hepatic lipid 
accumulation in this mouse strain.
PKC translocation in the liver. Differences in lipogenesis, lipolysis and fatty acid oxidative metabolism 
are potential mechanisms explaining strain-dependent differences in FR-induced hepatic TAG accumulation, 
however these differences are unlikely able to explain the retained glucose tolerance of FR-fed BALB/c mice. 
TAG are relatively inert lipid species, while it is thought that the more metabolically active lipid intermediates 
DAG and CER primarily affect glucose tolerance and insulin sensitivity28,29. The strain-dependent differences in 
DAG accumulation, particularly PUFA-DAG (Fig. 2), potentially suggested that alterations in this lipid class may 
partially contribute to the disparate effects of fructose on glucose tolerance, as DAG are known to stimulate the 
translocation of PKC isoforms to the plasma membrane which impair insulin signalling at the level of the insu-
lin receptor (IR) and insulin receptor substrates (IRS)29,30. To determine if PKC translocation was differentially 
affected by FR-feeding in the two mouse strains, we carried out a fractionation procedure to separate the cytosolic 
and membrane compartments, and examined distribution of various PKC isoforms by immunoblotting. Using a 
pan-PKC antibody, we observed that both cytosolic and membrane levels of PKC remained unaffected by diet in 
BALB/c mice, while total PKC content increased in BL6 mouse livers after FR-feeding in both compartments (to 
a greater extent in the membrane fraction: + 60% [membrane/cytosol]) (Fig. 5A). Furthermore, FR-fed BL6 mice 
exhibited a significant increase in the conventional protein kinases PKCα and PKCβ 1 in the membrane fraction 
(Fig. 5A), while no change in translocation of these isoforms was observed in FR-fed BALB/c mice. In addition, 
translocation of the novel protein kinase PKCɛ was unchanged by diet in BL6 mice, but was significantly decreased 
in FR-fed BALB/c mice (Fig. 5A).
C57BL/6 BALB/c
CHOW FRU CHOW FRU
Food Intake (kcal/mouse/day) 10.60 ± 0.55 11.82 ± 0.41 8.83 ± 0.32 9.76 ± 0.35
Liver (%) 4.22 ± 0.20 4.18 ± 0.16 4.83 ± 0.16 4.54 ± 0.08
Epi.WAT (%) 1.18 ± 0.06 1.42 ± 0.11* 2.41 ± 0.13 3.04 ± 0.12**
Ing.WAT (%) 0.93 ± 0.04 1.14 ± 0.05** 1.87 ± 0.21 2.21 ± 0.08***
Retro.WAT (%) 0.26 ± 0.03 0.35 ± 0.03* 0.97 ± 0.06 1.27 ± 0.06**
BAT (%) 0.24 ± 0.01 0.26 ± 0.01 0.36 ± 0.03 0.37 ± 0.03
Plasma TAG (μ mol/ml) 2.04 ± 0.23 1.56 ± 0.26* 1.86 ± 0.19 1.30 ± 0.09**
Plasma NEFA (μ mol/ml) 0.62 ± 0.05 0.48 ± 0.05* 0.47 ± 0.04 0.60 ± 0.03*
Fasting Glucose (mM) 8.44 ± 0.49 7.55 ± 0.28 7.73 ± 0.36 7.01 ± 0.17
Fasting Insulin (ng/ml) 1.17 ± 0.30 0.92 ± 0.12 1.05 ± 0.07 1.10 ± 0.09
Table 1.  Food intake, tissue weights and circulating factors in chow- and fructose-fed C57BL/6 and 
BALB/c mice. Tissue weights are expressed as ‘percent of body weight’. Epi.WAT epididymal white adipose 
tissue; Ing.WAT Inguinal white adipose tissue; Retro.WAT retroperitoneal white adipose tissue; BAT brown 
adipose tissue; TAG triacylglycerol; NEFA non-esterified fatty acids. Shown are means ± SEM, n = 7–8 for each 
measure, *p < 0.05, **p < 0.01, ***p < 0.001.
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Effects of fructose-feeding on insulin signalling and ER stress in liver. Despite increased activation 
of several hepatic PKC isoforms in FR-fed BL6 mice, insulin stimulations in vivo did not reveal any impairment 
in components of the insulin signalling cascade in the liver, including unchanged phosphorylation of IR, the 
protein kinase Akt and glycogen synthase kinase β (GSK3β ) (Fig. 5B). Similarly, insulin signalling was unaffected 
by FR-feeding in livers of BALB/c mice (Fig. 5B). Endoplasmic reticulum (ER) stress has been implicated as an 
important mediator of insulin resistance31–34, and was also shown to be increased under high-fructose conditions 
in rodents10,13,15. To examine changes in ER stress after FR-feeding, we examined several ER stress markers in 
the liver by immunoblotting (Fig. 5C). Phosphorylation (= activation) of eukaryotic initiation factor 2α (Elf2α ), 
inositol-requiring enzyme 1 (IRE1) and c-Jun N-terminal kinase (JNK) were significantly increased in FR-fed 
BL6 mice, whereas Elf2α and JNK phosphorylation were completely absent or unchanged in FR-fed BALB/c mice 
and IRE1 phosphorylation was increased to a lesser extent (+ 190% in BALB/c mice vs. + 350% in BL6 mice). The 
expression of C/EBP homologous protein (CHOP) was significantly increased in FR-fed BL6 mice, but reduced 
in FR-fed BALB/C mice. Activating transcription factor 6 (ATF6), 78 kDa glucose-regulated protein (GRP78) and 
heat shock protein 70 (HSP70) protein levels were unaffected by diet in both mouse strains (Fig. 5C).
Lipid metabolism, insulin signalling and ER stress in muscle. Whereas BALB/c mice exhibited pro-
found protection against FR-induced ectopic TAG accumulation in the liver, this protection was not present in 
skeletal muscle, with substantial TAG accumulation in BALB/c mice, to an even greater extent than observed for 
FR-fed BL6 mice (Fig. 6B). Markers of lipid metabolism and oxidative capacity were assessed to determine the 
potential causes of TAG accumulation. In both strains there was a substantial increase in total ACC2 content after 
FR-feeding, while markers of fatty acid entry into muscle (measured as protein content of the fatty acid transport 
proteins CD36, FATP2 and FATP4) were reduced (Fig. 6A). The levels of various proteins involved in oxidative 
metabolism (subunits of ETC complexes, PGC1α , uncoupling protein 3 (UCP3) and voltage-dependent anion 
channel (VDAC, used as a marker of mitochondrial content)), exhibited only minimal differences between strains 
Figure 2. Hepatic lipid accumulation in chow- and fructose-fed BL6 and BALB/c mice. Shown are total 
triacylglycerol (A), diacylglycerols (DAG, B) and ceramide (C) levels, as well as hepatic content of saturated 
DAG (D), monounsaturated DAG (E) and polyunsaturated DAG (F), and accumulation of 16:0_20:4 (G), 
18:0_20:4 (H) and 18:1_20:4 (I) DAG species. Black bars = chow-fed mice, grey bars = fructose-fed mice; 
shown are means ± SEM, with n = 4–5; *p < 0.05, **p < 0.01, ***p < 0.001.
www.nature.com/scientificreports/
6Scientific RepoRts | 5:18474 | DOI: 10.1038/srep18474
and diets (Fig. 6A). However, as also observed in the liver, we found discrepancy between the content of specific 
mitochondrial proteins and the activity of oxidative enzymes in skeletal muscle. In BL6 mice, FR-feeding led to 
a decrease in citrate synthase activity (Fig. 6C) with no change in β HAD activity (Fig. 6D), whereas in FR-fed 
BALB/c mice both oxidative proteins showed increased activity. In addition to hepatic insulin signalling, we also 
investigated changes in IR, Akt and GSK3β phosphorylation under insulin-stimulated conditions in muscle. While 
insulin signalling remained unaffected by FR-feeding in BL6 mice (as observed for liver), FR-fed BALB/c mice 
exhibited decreased phosphorylation of IR and GSK3β (Fig. 7A). Furthermore, in BL6 mice ER stress markers 
(phosphorylation of IRE1 and Elf2α , as well as HSP70) were significantly increased with FR-feeding, while in 
BALB/c mice only phosphorylation of IRE1 exhibited an increase when compared to controls (Fig. 7B).
Discussion
This study highlights mouse strain-specific differences in the metabolic response to dietary intake of different 
nutrients and investigates possible mechanisms of fructose-induced metabolic deterioration. There is a large body 
of literature demonstrating that dietary intake of high amounts of fructose leads to fatty liver and the development 
of glucose intolerance and insulin resistance (reviewed in8). This metabolic phenotype was clearly present in BL6 
mice, which exhibited increased adiposity, ectopic lipid accumulation in liver and muscle, and developed glucose 
intolerance following a FR-enriched diet. Interestingly, BALB/c mice did not exhibit any deterioration of glucose 
intolerance, despite increased adiposity and muscle lipid accumulation. This favourable metabolic phenotype was 
Figure 3. Lipid metabolism in livers and primary hepatocytes of chow- and fructose-fed BL6 and BALB/c 
mice. (A) Immunoblotting for lipogenic, lipolytic and fatty acid uptake proteins. Shown is representative 
immunoblotting with n = 2 per mouse strain and diet, however percentage changes and significance were 
calculated with n = 8 per group. ACC acetyl-CoA carboxylase, FAS fatty acid synthase, SCD1 stearoyl-CoA 
desaturase 1, HSL hormone-sensitive lipase, ATGL adipose triglyceride lipase, FATP2/4 fatty acid transport 
proteins 2/4, CD36 Cluster of Differentiation 36. 14-3-3 was used as a loading control. (B) Triglyceride 
accumulation in primary hepatocytes isolated from BL6 and BALB/c mice fed a chow- or fructose-diet for 2 
weeks. (C) Lipogenic capacity of primary hepatocytes, measured as incorporation of [3H]H2O into the lipid 
pool, (D) Esterification rate of primary hepatocytes, measured as incorporation of 1-[14C]-palmitate into 
the lipid pool, and (E) lipolytic capacity, measured as the breakdown and oxidation of the [14C]-palmitate-
labelled triglyceride pool. Furthermore, we measured hepatic triglyceride production and secretion rate using 
Poloxamer 407 over a period of 6 hours in BL6 (F) and BALB/c (G) mice, as well as triglyceride (H) and NEFA 
(I) secretion in primary hepatocytes. Shown are means ± SEM, with n = 4–5 mice (and 3 replicates per mouse) 
for the primary hepatocyte experiments, and n = 4 for the hepatic TAG secretion. Shown are means ± SEM, 
*p < 0.05, **p < 0.01, ***p < 0.001.
www.nature.com/scientificreports/
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associated with a marked difference in hepatic lipid profile, including reduced TAG accumulation and a reduction 
in the levels of polyunsaturated DAG species (PUFA-DAG). The improved glucose clearance in FR-fed BALB/c 
mice was also associated with a reduction in hepatic ER stress markers and a mild elevation in circulating insulin 
levels during the GTT.
The DAG-PKC axis is frequently suggested as an important mechanism of lipid-induced insulin resistance in the 
liver, through antagonism of the insulin signalling cascade29,30. In BL6 mice the overall content of DAG was elevated 
and the content of PUFA-DAG tended to also increase with FR-feeding, with several 20:4-containing species being 
significantly elevated (16:0/20:4, 18:0/20:4 and 18:1/20:4). In BALB/c mice the increase in specific PUFA-DAG 
species was either blunted or even decreased after FR-feeding (especially DAG species 18:0/20:4 was reduced). 
In vitro comparisons of various DAG species and their ability to activate PKCs suggests that polyunsaturated DAG, 
and especially DAG containing arachidonic acid (20:4) are particularly effective at inducing PKC activation26,27,35. 
Indeed, the elevated 20:4-containing DAG species in FR-fed BL6 mice were associated with increased activation 
of PKCα and to an even greater extent of PKCβ 1 after FR-feeding, whereas no activation of these PKC isoforms 
was observed in BALB/c mouse livers. The PKC isoform that has been most extensively linked to lipid-induced 
insulin resistance in liver is PKCɛ , with its activation frequently documented as a mechanism interconnecting 
hepatic DAG accumulation and insulin resistance (reviewed in36). We observed no increase in the activation of 
this PKC isoform in BL6 mice under our experimental conditions, and PKCɛ activation was mildly decreased in 
liver of FR-fed BALB/c mice. Despite the significant increase in the activation of the conventional PKC isoforms 
PKCα and PKCβ in FR-fed BL6 mice, hepatic insulin signalling was unaffected by FR-feeding in both strains in 
our study, potentially indicating that PKCɛ is indeed the critical hepatic PKC isoform that antagonises insulin 
signalling during the development of insulin resistance, as proposed previously9,37–39. It is also possible that in this 
experimental model, like others recently reported40–43, there is not a straight-forward relationship between insulin 
resistance and DAG accumulation/PKC activation. In muscle we also observed no impairment in insulin signalling 
that might explain the impaired glucose tolerance in FR-fed BL6 muscle, however DAG accumulation and PKC 
activation were not directly examined in this tissue. Collectively our findings suggest that in response to dietary 
fructose overload, factors beyond changes in insulin signal transduction might be more important regulators of 
glucose homeostasis.
Figure 4. Oxidative metabolism in livers and primary hepatocytes of chow- and fructose-fed BL6 and 
BALB/c mice. (A) Immunoblotting for oxidative markers, including complexes II-V (subunits of complexes of 
the electron transport chain), CPT1 carnitine palmitoyl transferase 1, PGC1 peroxisome proliferator-activated 
receptor c coactivator 1, SOD2 superoxide dismutase 2, TFAM mitochondrial transcription factor A. 14-3-3 
was used as a loading control. Shown is representative immunoblotting with n = 2 per mouse strain and diet, 
however percentage changes and significance were calculated with n = 8 per group. (B) Citrate synthase and 
(C) β HAD activity in liver homogenates, and (D) palmitate oxidation in primary hepatocytes. Shown are 
means ± SEM, n = 7–8 for liver homogenates and n = 4–5 mice (and 3 replicates per mouse) for the primary 
hepatocyte experiments, *p < 0.05, **p < 0.01.
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Another factor linked to the development of insulin resistance is ER stress34. Upon increased ER stress, cells 
respond by activating three parallel but interconnected pathways of the unfolded protein response (UPR), the 
IRE1/XBP1 arm, the PERK/elf2α and the ATF6 arm, as an attempt to resolve the elevation in cellular stress44. In the 
present study, we have shown that FR-fed BL6 mice exhibit an induction of two arms of UPR, the IRE1/XBP1 arm 
as well as the PERK/elf2α arm. In contrast, in FR-fed BALB/c mice activation of the IRE1/XBP1 arm was blunted 
whereas signalling through the PERK/elf2α and the ATF6 arms was completely absent. ER stress is suggested to be 
a major contributor to the development of hepatic insulin resistance, by (1) increasing de novo lipogenesis and (2) 
activating the c-Jun N-terminal kinase (JNK) and IkB kinase (IKK) pathway and subsequently inhibiting hepatic 
insulin signalling34. Our results suggest that the variable response in ER stress signalling in response to FR-feeding 
in BL6 and BALB/c mice might be more closely related to changes in lipogenesis than insulin signalling, as neither 
strain showed a defect in hepatic insulin signalling, but we did observe increased lipid synthesis in hepatocytes 
from the BL6 strain, where ER stress markers were higher. A recent study in FR-fed mice treated with fenofibrate 
similarly showed that activation of ER stress markers correlates very closely with lipogenesis in the liver10. In 
addition to lipid synthesis, activation of the ER stress pathway has also been shown to affect glucose homeostasis 
by directly regulating gluconeogenic pathways and glucose tolerance45–47, and it is possible that the impairment in 
glucose tolerance in FR-fed BL6 mice in the current study might also be related to direct effects of cellular stress 
on gluconeogenesis and hepatic glucose output.
Figure 5. PKC activation, insulin signalling and markers of endoplasmic reticulum (ER) stress in livers of 
chow- and fructose-fed BL6 and BALB/c mice. (A) Cytosolic and membrane-associated content of protein 
kinase C isoforms. (B) Phosphorylation status of the insulin receptor (IR), the protein kinase Akt and glycogen 
synthase kinase 3β (GSK3β ) was determined in livers after 8 weeks dietary intervention and 15 min of insulin 
stimulation at 2 U/kg lean mass. (C) Activation of ER stress pathways was determined as phosphorylation 
status of Elf2a (E74-like factor 2a), IRE1 (Inositol-requiring enzyme-1) and JNK (c-Jun N-terminal kinase), 
and protein content of ATF6 (activating transcription factor 6), GRP78 (78 kDa glucose-regulated protein), 
Chop (C/EBP homologous protein) and HSP70 (heat shock protein 70). 14-3-3 was used as a loading control. 
Shown is representative immunoblotting with n = 2 per mouse strain and diet, however percentage changes and 
significance were calculated with n = 5–8 per group. *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 6. Lipid and oxidative metabolism in quadriceps muscle. (A) Immunoblotting results for markers 
of fatty acid uptake and oxidative metabolism. Shown is representative immunoblotting with n = 2 per mouse 
strain and diet, however percentage changes and significance were calculated with n = 8 per group. ACC acetyl-
CoA carboxylase, CD36 cluster of differentiation 36, FATP2/4 fatty acid transport proteins 2/4, complexes 
II-V subunits of complexes of the electron transport chain, CPT1 carnitine palmitoyl transferase 1, VDAC 
mitochondrial outer membrane protein porin, UCP3 uncoupling protein 3, PGC1 peroxisome proliferator-
activated receptor c coactivator 1. GAPDH was used as a loading control. (B) Muscle triglyceride content,  
(C) citrate synthase and (D) β HAD activity of muscle homogenates. Shown are means ± SEM, with n = 6–8 per 
group, *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 7. Insulin signalling and markers of endoplasmic reticulum (ER) stress in quadriceps muscle of 
chow- and fructose-fed BL6 and BALB/c mice. (A) Phosphorylation status of the insulin receptor (IR), the 
protein kinase Akt and glycogen synthase kinase 3β (GSK3β ) was determined in livers after 8 weeks dietary 
intervention and 15 min of insulin stimulation at 2 U/kg lean mass. (B) Activtion of ER stress pathways was 
determined as phosphorylation status of Elf2a (E74-like factor 2a) and IRE1 (Inositol-requiring enzyme-1) 
and protein content of HSP70 (heat shock protein 70). GAPDH was used as a loading control. Shown is 
representative immunoblotting with n = 2 per mouse strain and diet, however percentage changes and 
significance were calculated with n = 5–8 per group. *p < 0.05, **p < 0.01, ***p < 0.001.
www.nature.com/scientificreports/
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A further factor potentially contributing to some extent to the observed strain-specific differences in glucose 
tolerance was an alteration in circulating insulin during the GTT. FR-fed BALB/c mice exhibited a mild increase 
in insulin levels at some of the later points during the GTT, however this elevation was not seen in FR-fed BL6 
mice. Fructose is not thought to have a major direct impact on insulin secretion48, although it has been reported 
that dietary fructose may change the insulin response to a subsequent glucose challenge in rodents49. It is currently 
unclear what underpins the strain-dependent difference in insulin response and whether the mild elevation in 
insulin levels in FR-fed BALB/c mice in the present study reflects altered insulin secretion or a change in insulin 
clearance in the liver.
The contrast in the accumulation of hepatic TAG between FR-fed BL6 and BALB/c mice was also intriguing, 
particularly since DAG levels were significantly elevated in both strains. The degree of lipid accumulation in the 
liver is the result of a complex interplay between fatty acid influx, de novo lipogenesis, fatty acid oxidation and 
lipid export pathways. In a recent report we showed that unlike other strains, hepatic TAG levels remained largely 
unchanged in BALB/c mice fed a high-fat diet compared to low-fat controls, with differences in fatty acid uptake 
proteins potentially explaining the disparate effects between strains24. An enhanced rate of lipogenesis is considered 
the primary mechanism underpinning hepatic lipid deposition with dietary fructose and, whereas both strains 
exhibited marked induction in the protein content of lipogenic enzymes such as ACC, FAS and SCD-1, lipogenic 
capacity in primary hepatocytes (determined as incorporation of [3H]-H2O into the lipid pool) was increased in 
FR-fed BL6, but not in BALB/c animals. In addition to lower lipogenic activity in FR-fed BALB/c mice, tracer work 
in primary hepatocytes also suggested increased lipolytic and oxidative capacity in this strain. In line with these 
findings, recent work has shown in skeletal muscle that direct upregulation of lipolysis by ATGL overexpression can 
lead to enhanced mitochondrial capacity and fatty acid oxidation50. Our findings indicate that the lack of hepatic 
lipid accumulation in BALB/c mice was likely due to adaptations in several metabolic pathways, and potentially 
suggest that newly synthesised fatty acids in FR-fed BL6 mice are channelled into TAG pools which are less readily 
broken down, while TAG in FR-fed BALB/c mice may be more readily degraded hence leading to minimal overall 
change in TAG content.
There is a substantial body of literature demonstrating that high fructose intake increases the risks of devel-
oping metabolic disease (reviewed in1). Comparing fructose-induced differences in metabolic phenotype in two 
commonly used mouse strains we have highlighted the multifactorial nature of metabolic defects that develop in 
response to altered intake of specific dietary nutrients. Additionally we have shown that while some metabolic 
adaptations to elevated fructose intake are common to C57BL/6 mice and BALB/c mice, there are also marked 
strain-specific differences, further emphasising the importance of considering the genetic background of mice 
when undertaking metabolic studies.
Methods
Ten-week old C57BL/6J and BALB/c mice were purchased from the Australian Resource Centre (Perth, Australia). 
Mice were maintained in a temperature-controlled room (22 °C ± 1 °C) with a 12-hour light/dark cycle and ad 
libitum access to water and experimental diets15,51. After one week on a standard control “chow” diet (71% of 
calories from carbohydrate as wheat/starch, 8% calories from fat, 21% calories from protein, ~3kcal/g; Gordon’s 
Specialty Stock Feeds, Yanderra, NSW, Australia), mice were randomly allocated to remain on the chow diet (C) 
or to receive a home-made diet enriched in fructose (FR; 35% of calories from fructose, 35% calories from starch, 
10% calories from fat, 20% calories from protein, ~3.1kcal/g) ad libitum for 8 weeks (or 2 weeks for primary hepat-
ocyte experiments). All experiments were approved by the University of New South Wales Animal Care and Ethics 
Committee, and followed guidelines issued by the National Health and Medical Research Council of Australia.
Body composition and energy expenditure. Fat mass was measured using the EchoMRI-900 Body 
Composition Analyser (EchoMRI Corporation Pte Ltd, Singapore) in accordance with the manufacturer’s instruc-
tions. Heat production and respiratory exchange ratio (RER) of individual mice were measured using an Oxymax 
indirect calorimeter (Columbus Instruments, Columbus, OH, USA) as previously described52.
Glucose tolerance, insulin levels and in vivo insulin stimulations. Mice were fasted for 6 hours and 
then injected intraperitoneally with glucose (2 g/kg); blood glucose levels were monitored over time using an 
Accu-check II glucometer (Roche Diagnostics, Castle Hill, NSW, Australia). Fasting blood insulins as well as insu-
lin levels during the GTT were measured using an Ultrasensitive Mouse Insulin Elisa Kit (Crystal Chem, Illinois, 
USA). For in vivo insulin stimulations, mice were fasted overnight and given an intraperitoneal injection of insulin 
at 2U/kg lean mass, with tissues rapidly excised and snap frozen 15 min after the injection.
Tissue lipid analyses and lipid secretion. Tissue and media triglyceride contents were determined 
using a colorimetric assay kit (Triglycerides GPO-PAP; Roche Diagnostics, Indianapolis, IN, USA) as previously 
described53. Similarly, plasma NEFAs (and NEFAs in primary hepatocyte media) were measured using a colori-
metric kit (WAKO diagnostics, Osaka, Japan). For diacyglycerol (DAG) and ceramide measurements, lipids were 
extracted in solvents54 containing 2 nmoles of ceramide (17:0) and 10 nmoles of DAG (17:0/17:0) as internal 
standards for quantification, and samples were analysed by mass spectrometry as described previously24. Hepatic 
triglyceride production rate was measured using Poloxamer 407 over a period of 6 hours, as described previously55.
Primary hepatocyte isolation. Primary hepatocytes were isolated by collagenase perfusion. Briefly, liver was 
perfused through the inferior vena cava with EGTA buffer (HBSS buffer + 0.5 mmol/l EGTA) for 15 min, followed 
by collagenase digestion (Collagenase H, Roche) in calcium buffer (HBSS buffer + 2 mmol/l CaCl2) for 9 min. 
Hepatocytes were plated on collagenase-coated 6-well plates with 500,000 cells per well, firstly in adherence media 
(Gibco M199 media + 100 U Penicillin/Streptomycin, 0.1% BSA, 2% FBS, 100 nmol/l Dexamethasone, 100 nmol/l 
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Insulin) for 4 hours, then in basal media (Gibco M199 media + 100 nmol/l Dexamethasone, 1 nmol/l Insulin) over-
night, in the presence or absence of 2 mmol/l fructose in the media. For TAG and NEFA secretion into the media, 
basal media was collected after overnight incubation and TAG/NEFA levels are expressed per hour and mg protein.
Analysis of lipogenic, lipolytic and enzyme activities. Lipogenic capacity was measured as the incor-
poration of [3H]H2O (0.2 mCi/ml) into the lipid pool over a 2-hour period. Lipids were extracted using the Folch 
procedure as described previously56 and incorporation of 3H into the lipid fraction was assessed. Measurement 
of the esterification rate and lipolytic capacity were set up in the form of a pulse-chase experiment. Hepatocytes 
were incubated in basal media (± fructose) in the presence of 200 μ mol/l palmitate (conjugated to 1% BSA) and 
1-[14C]-palmitate (2 μ Ci/ml) for a period of 2.5 hours. After the priming period, a subset of hepatocytes was 
analysed to determine the esterification rate (= amount of palmitate incorporated into the lipid pool). All other 
cells were washed, fresh media (± fructose) applied and the lipolytic capacity determined in a subsequent 1-hour 
incubation period. Lipolytic capacity was measured as the breakdown of labelled triglycerides and appearance of 
the [14C]-carbon in CO2 and the lipid and aqueous fractions in the media. In addition, we measured the ability 
of hepatocytes to oxidise exogenous 1-[14C]-palmitate. Cells were incubated in basal media (± fructose) in the 
presence of 200 μ mol/l palmitate (conjugated to 1% BSA) and 1-[14C]-palmitate (0.5 μ Ci/ml) for one hour. At the 
conclusion of the assay the media was acidified with 1 mol/l perchloric acid and palmitate oxidation was determined 
as the accumulation of [14C]-carbon in the CO2 and the acid-soluble metabolite (ASM) fraction. Citrate synthase, 
β HAD and fructokinase activities were measured as described previously52,57.
Liver fractionation. Liver fractionation was carried out as described previously58. Briefly, liver tissue was 
homogenised in 4 volumes of homogenisation buffer (20 mmol/1 MOPS, pH 7.5, 250 mmol/1 mannitol, 1.2 mmol/1 
EGTA, 200 μ g/ml leupeptin, 2 mmol/l benzamidine, and 2 mmol/1 phenylmethylsulfonyl fluoride (PMSF)) in a 
Precellys (Sapphire Bioscience, Waterloo, NSW, Australia) at 6 m/sec for 30 sec, followed by ultracentrifugation at 
175.000 g and 4 °C for 15 min. The supernatant (= cytosolic fraction) was frozen for subsequent immunoblotting. 
The pellet was resuspended in homogenisation buffer, recentrifuged at the same speed, the supernatant discarded 
and the pellet resuspended in solubilisation buffer (20 mmol/1 MOPS, pH 7.5, 1% (vol/vol) Triton X-100,  mmol/1 
EDTA, 2 mmol/1 EGTA, 200 μ g/ml leupeptin, 2 mmol/1 benzamidine, and 2 mmol/1 PMSF). After nutation for 
1 hour at 4 °C, the samples were centrifuged at 175,000 g and 4 °C for 15 min, and the supernatant (= membrane 
fraction) frozen for subsequent immunoblotting.
Immunoblotting. Whole-tissue lysates were prepared from powdered quadriceps muscle and liver on a 
Precellys (Sapphire Bioscience Australia) at 6 m/sec for 30 sec, in RIPA buffer59. Proteins were resolved by SDS-PAGE 
electrophoresis and immunoblot analysis was conducted as described elsewhere51,52,59,60. Immunolabelled bands 
were quantitated using ImageJ 1.44p software.
Statistical analysis. All results are presented as mean ± standard error. Data were analysed with an unpaired 
student’s t-test. Statistical significance was accepted at P < 0.05.
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